Risk of disease progression in first-line metastatic colorectal cancer therapy to guide disease reassessments―analysis of 11 trials by AIO and GONO

The distribution of PD events does not follow a Gaussian pattern, with the highest density observed between the third and fourth reassessment of a bimonthly surveillance schedule. In clearly unresectable patients, restaging should focus on the interval between 6 and 10 months and not on the initiation of systemic therapy. Our model might be helpful to schedule radiological reassessments according to baseline characteristics, early response and the expected duration of each treatment efficacy.

Authors

Institutions

Publication Details

Journal
Annals of Oncology
Published
2025-08-20
DOI
https://doi.org/10.1016/j.annonc.2025.08.001
Citations
4
Primary Topic
Colorectal Cancer Treatments and Studies
Type
article
Field-Weighted Citation Impact
4.18

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Risk of disease progression in first-line metastatic colorectal cancer therapy to guide disease reassessments―analysis of 11 trials by AIO and GONO

Martin Fuchs, V. Heinemann, Lena Weiss, S. Stintzing et al.
4 citations
Annals of Oncology
Colorectal Cancer Treatments and Studies
4.18
article

Risk of disease progression in first-line metastatic colorectal cancer therapy to guide disease reassessments―analysis of 11 trials by AIO and GONO

Martin Fuchs, V. Heinemann, Lena Weiss, S. Stintzing, Arndt Stahler, C. Antoniotti, Thomas Decker, Paolo Frumento, S. Lonardi, Gabriele Masi, F. Bergamo, Dominik Paul Modest, Federica Morano, Davide Rossini, Kathrin Heinrich, Florian Kaiser, L. Salvatore, F. Pietrantonio, C. Cremolini, Ludwig Fischer von Weikersthal, M M Germani
article en
4 citations

Abstract

The distribution of PD events does not follow a Gaussian pattern, with the highest density observed between the third and fourth reassessment of a bimonthly surveillance schedule. In clearly unresectable patients, restaging should focus on the interval between 6 and 10 months and not on the initiation of systemic therapy. Our model might be helpful to schedule radiological reassessments according to baseline characteristics, early response and the expected duration of each treatment efficacy.

Annals of OncologyVol. 36(11)
University of Pisa (IT), University of Applied Sciences Landshut (DE), München Klinik Bogenhausen (DE), Istituto Oncologico Veneto (IT), MVZ Labor Ravensburg (DE), Klinikum St. Marien Amberg (DE), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), University of Florence (IT), Charité - Universitätsmedizin Berlin (DE), Ludwig-Maximilians-Universität München (DE)
European Commission
Good health and well-being
Openalex Percentile: Top 5%
Colorectal Cancer Treatments and Studies
4.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.